Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Pharmacology and Therapeutics

• Publication date

  2017-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.pharmthera.2017.10.017PMID 29080702
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Immunotherapy in brain tumors].

  2017cited by this paper
• Mevalonate Cascade Inhibition by Simvastatin Induces the Intrinsic Apoptosis Pathway via Depletion of Isoprenoids in Tumor Cells

  2017cited by this paper
• Retraction Notice to: Vulnerability of Glioblastoma Cells to Catastrophic Vacuolization and Death Induced by a Small Molecule

  2017cited by this paper
• Adult Glioblastoma.

  2017cited by this paper
• Bax Activation Blocks Self-Renewal and Induces Apoptosis of Human Glioblastoma Stem Cells.

  2017influential reference
• Short‐Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma

  2017cited by this paper
• Advances in the molecular genetics of gliomas — implications for classification and therapy

  2017cited by this paper
• HIF1α regulates glioma chemosensitivity through the transformation between differentiation and dedifferentiation in various oxygen levels

  2017influential reference
• Immunotherapy for Brain Tumors.

  2017cited by this paper
• New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targets

  2017cited by this paper
• Dovitinib enhances temozolomide efficacy in glioblastoma cells

  2017cited by this paper
• DNA Repair Capacity in Multiple Pathways Predicts Chemoresistance in Glioblastoma Multiforme.

  2017cited by this paper
• Temozolomide in combination with metformin act synergistically to inhibit proliferation and expansion of glioma stem-like cells

  2016influential reference
• Glioblastoma care in the elderly

  2016cited by this paper
• MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM

  2016cited by this paper
• Antiangiogenic Therapy for Glioblastoma: Complex Biology and Complicated Results.

  2016cited by this paper
• Tumor treating fields: a novel treatment modality and its use in brain tumors

  2016cited by this paper
• TTFields: where does all the skepticism come from?

  2016cited by this paper
• A fate worse than death.

  2016cited by this paper
• miR-29c contribute to glioma cells temozolomide sensitivity by targeting O6-methylguanine-DNA methyltransferases indirectly

  2016cited by this paper
• Inhibition of STAT3 enhances the radiosensitizing effect of temozolomide in glioblastoma cells in vitro and in vivo

  2016cited by this paper
• MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma

  2016cited by this paper
• Knockdown of retinoblastoma protein may sensitize glioma cells to cisplatin through inhibition of autophagy.

  2016cited by this paper
• ER stress in temozolomide-treated glioblastomas interferes with DNA repair and induces apoptosis

  2016cited by this paper
• How to train glioma cells to die: molecular challenges in cell death

  2016influential reference
• CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013.

  2016influential reference
• BIRC3 is a novel driver of therapeutic resistance in Glioblastoma

  2016cited by this paper
• NOTCH blockade combined with radiation therapy and temozolomide prolongs survival of orthotopic glioblastoma

  2016cited by this paper
• Alterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells

  2016cited by this paper
• mTOR inhibitors in cancer therapy

  2016cited by this paper
• Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation

  2016cited by this paper
• Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells

  2016cited by this paper
• XBP1 silencing decreases glioma cell viability and glycolysis possibly by inhibiting HK2 expression

  2016influential reference
• HMGA2 sustains self-renewal and invasiveness of glioma-initiating cells

  2016cited by this paper
• Ubiquitin-Dependent And Independent Signals In Selective Autophagy.

  2016cited by this paper
• Potential role of Shh-Gli1-BMI1 signaling pathway nexus in glioma chemoresistance

  2016cited by this paper
• Isocitrate dehydrogenase mutations in gliomas.

  2016cited by this paper
• Suppression of autophagy impedes glioblastoma development and induces senescence

  2016cited by this paper
• Single-Cell Phosphoproteomics Resolves Adaptive Signaling Dynamics and Informs Targeted Combination Therapy in Glioblastoma.

  2016cited by this paper
• Migrating glioma cells express stem cell markers and give rise to new tumors upon xenografting

  2016cited by this paper
• The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma.

  2016cited by this paper
• Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide.

  2016cited by this paper
• A paired comparison between glioblastoma “stem cells” and differentiated cells

  2016cited by this paper
• Synergistic increase in efficacy of a combination of 2-deoxy-d-glucose and cisplatin in normoxia and hypoxia: switch from autophagy to apoptosis

  2016cited by this paper
• The renewed battle against RAS-mutant cancers

  2016cited by this paper
• Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.

  2016cited by this paper
• Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial

  2016cited by this paper
• Nitrosoureas in the Management of Malignant Gliomas

  2016cited by this paper
• p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading

  2016cited by this paper
• The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

  2016influential reference
• Augmented HR Repair Mediates Acquired Temozolomide Resistance in Glioblastoma

  2016cited by this paper
• Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets

  2016cited by this paper
• Ursolic acid attenuates temozolomide resistance in glioblastoma cells by downregulating O(6)-methylguanine-DNA methyltransferase (MGMT) expression.

  2016cited by this paper
• Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial.

  2016cited by this paper
• Control of glioblastoma tumorigenesis by feed-forward cytokine signaling

  2016cited by this paper
• Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression

  2016cited by this paper
• GSK621 Targets Glioma Cells via Activating AMP-Activated Protein Kinase Signalings

  2016cited by this paper
• ABCG2 regulates self-renewal and stem cell marker expression but not tumorigenicity or radiation resistance of glioma cells

  2016influential reference
• Apoptosis, autophagy and unfolded protein response pathways in Arbovirus replication and pathogenesis

  2016influential reference
• Protein Analysis of Glioblastoma Primary and Posttreatment Pairs Suggests a Mesenchymal Shift at Recurrence

  2016cited by this paper
• A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways

  2016cited by this paper
• Effect of chloroquine on some clinical and biochemical parameters in non-response chronic hepatitis C virus infection patients: pilot clinical trial.

  2016cited by this paper
• Targeting autophagy to sensitive glioma to temozolomide treatment

  2016cited by this paper
• New use of an old drug: chloroquine reduces viral and ALT levels in HCV non-responders (a randomized, triple-blind, placebo-controlled pilot trial).

  2016cited by this paper
• Retinoblastoma Binding Protein 4 Modulates Temozolomide Sensitivity in Glioblastoma by Regulating DNA Repair Proteins.

  2016cited by this paper
• Astrocytes promote glioma invasion via the gap junction protein connexin43

  2016cited by this paper
• mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance

  2016cited by this paper
• The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma.

  2016cited by this paper
• Autophagy enhancement contributes to the synergistic effect of vitamin D in temozolomide-based glioblastoma chemotherapy

  2016cited by this paper
• Inhibition of Dopamine Receptor D4 Impedes Autophagic Flux, Proliferation, and Survival of Glioblastoma Stem Cells.

  2016cited by this paper
• Akt and β-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line.

  2016cited by this paper
• Physiological and Pharmacological Control of BAK, BAX, and Beyond.

  2016cited by this paper
• Microenvironment and autophagy cross-talk: Implications in cancer therapy.

  2016cited by this paper
• Autophagy mediates degradation of nuclear lamina

  2015cited by this paper
• Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo

  2015cited by this paper
• Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?

  2015cited by this paper
• Interferon-α/β enhances temozolomide activity against MGMT-positive glioma stem-like cells.

  2015cited by this paper
• Cancer stem cells in glioblastoma

  2015cited by this paper
• Glioma cells escaped from cytotoxicity of temozolomide and vincristine by communicating with human astrocytes

  2015influential reference
• Beyond the World Health Organization grading of infiltrating gliomas: advances in the molecular genetics of glioma classification.

  2015cited by this paper
• Detection of CD133 expression in U87 glioblastoma cells using a novel anti-CD133 monoclonal antibody.

  2015cited by this paper
• The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide.

  2015cited by this paper
• Minor Changes in Expression of the Mismatch Repair Protein MSH2 Exert a Major Impact on Glioblastoma Response to Temozolomide.

  2015cited by this paper
• PERK silence inhibits glioma cell growth under low glucose stress by blockage of p-AKT and subsequent HK2's mitochondria translocation

  2015influential reference
• Temozolomide resistance and tumor recurrence: Halting the Hedgehog.

  2015cited by this paper
• BC3EE2,9B, a synthetic carbazole derivative, upregulates autophagy and synergistically sensitizes human GBM8901 glioblastoma cells to temozolomide

  2015influential reference
• Hepatitis B and C virus-induced hepatitis: Apoptosis, autophagy, and unfolded protein response.

  2015cited by this paper
• Endothelial cells induce cancer stem cell features in differentiated glioblastoma cells via bFGF

  2015cited by this paper
• Single-cell analysis challenges the connection between autophagy and senescence induced by DNA damage

  2015influential reference
• Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance

  2015cited by this paper
• Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis.

  2015cited by this paper
• Oxidative stress inhibits growth and induces apoptotic cell death in human U251 glioma cells via the caspase-3-dependent pathway.

  2015cited by this paper
• Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide

  2015cited by this paper
• Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs

  2015cited by this paper
• Role of the salt bridge between glutamate 546 and arginine 907 in preservation of autoinhibited form of Apaf-1.

  2015cited by this paper
• Autophagy in malignant transformation and cancer progression

  2015cited by this paper
• Coculture with astrocytes reduces the radiosensitivity of glioblastoma stem-like cells and identifies additional targets for radiosensitization

  2015cited by this paper
• Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment

  2015cited by this paper
• Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence

  2015cited by this paper
• Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression

  2015cited by this paper

• CPUK02 sensitizes U87 glioblastoma cell lines to TMZ treatment via autophagy flux inhibition

  2026cites this paper
• The effect of chemotherapeutic agents on epidermal neural crest stem cells

  2025cites this paper
• Design, Synthesis, in vitro Anticancer Activity, Topoisomerase-I Inhibition and DNA Binding Studies of Substituted Carbazole Semicarbazone Derivatives

  2025cites this paper
• Effect of 30-day Ramadan fasting on autophagy pathway and metabolic health outcome in healthy individuals

  2025cites this paper
• Bufalin enhanced temozolomide efficacy by promoting EGFR protein degradation in glioblastoma.

  2025cites this paper
• Association of Hsa_circ_0059511 with the sensitivity of the temozolomide chemotherapeutic treatment in human glioma cells

  2025cites this paper
• Temozolomide Treatment in Refractory Pituitary Adenomas and Pituitary Carcinomas

  2025cites this paper
• Anticancer (cytotoxic, anticlonogenic, antimetastatic, immunomodulatory actions) properties of 3,5‐dibromosalicylaldehyde against glioblastoma cells and DFT analyses (FT‐IR, Raman, NMR, UV) as well as a molecular docking study

  2025cites this paper
• The aggrephagy-related gene TUBA1B influences clinical outcomes in glioma patients by regulating the cell cycle

  2025cites this paper
• Tumoroid Model Reveals Synergistic Impairment of Metabolism by Iron Chelators and Temozolomide in Chemo‐Resistant Patient‐derived Glioblastoma Cells

  2025cites this paper
• Protein misfolding and cancer - proteomics as an approach for biomarker discovery.

  2025cites this paper
• Antiproliferative effects and mitochondrial dysfunction of α-mangostin extracted from the pericarp of the mangosteen fruit (Garcinia mangostana L.) on rat C6 glioma cells.

  2025cites this paper
• Zwitterionic daptomycin mineralized gold nanoflowers based nanodrugs for enhanced anti-glioma therapy

  2025cites this paper
• PIK3CA Mutations: Are They a Relevant Target in Adult Diffuse Gliomas?

  2025cites this paper
• Amlodipine synergizes with temozolomide against glioma stem cells by modulating MGMT expression through downregulation of the AKT/GSK3β/β-catenin axis.

  2025cites this paper
• SARS-CoV-2 NSP6 reduces autophagosome size and affects viral replication via sigma-1 receptor

  2024cites this paper
• An Integrated Machine Learning Framework Identifies Prognostic Gene Pair Biomarkers Associated with Programmed Cell Death Modalities in Clear Cell Renal Cell Carcinoma.

  2024cites this paper
• Enhancing Temozolomide (TMZ) chemosensitivity using CRISPR-dCas9-mediated downregulation of O6-methylguanine DNA methyltransferase (MGMT)

  2024cites this paper
• Role of microRNA-505 during tumor progression and metastasis.

  2024cites this paper
• Biosensor-Enhanced Organ-on-a-Chip Models for Investigating Glioblastoma Tumor Microenvironment Dynamics

  2024cites this paper
• Unraveling the impact of noncoding RNAs in osteosarcoma drug resistance: a review of mechanisms and therapeutic implications.

  2024cites this paper
• Research Progress of Lipid Metabolism in Brain Glioma

  2024cites this paper
• Lovastatin-mediated pharmacological inhibition of Formin protein DIAPH1 suppresses tumor immune escape and boosts immunotherapy response.

  2024cites this paper
• Emerging role of IRE1α in vascular diseases

  2024cites this paper
• Recent Developments in Glioblastoma-On-A-Chip for Advanced Drug Screening Applications.

  2024cites this paper
• The Role of Mesenchymal Reprogramming in Malignant Clonal Evolution and Intra-Tumoral Heterogeneity in Glioblastoma

  2024cites this paper
• Erianin induces ferroptosis in GSCs via REST/LRSAM1 mediated SLC40A1 ubiquitination to overcome TMZ resistance

  2024cites this paper
• Programmed cell death disrupts inflammatory tumor microenvironment (TME) and promotes glioblastoma evolution

  2024cites this paper
• Metabolic Vulnerabilities of Temozolomide-Resistant Glioblastoma Cells: Implications for Targeted Therapies and Overcoming Chemoresistance

  2024cites this paper
• Role of microRNAs in tumor progression by regulation of kinesin motor proteins.

  2024cites this paper
• PXD101 inhibits malignant progression and radioresistance of glioblastoma by upregulating GADD45A

  2024cites this paper
• Brain gliomas: Diagnostic and therapeutic issues and the prospects of drug-targeted Nano-delivery technology.

  2024cites this paper
• Selenoprotein P expression in glioblastoma as a regulator of ferroptosis sensitivity: preservation of GPX4 via the cycling-selenium storage

  2024cites this paper
• A multifunctional targeted nano-delivery system with radiosensitization and immune activation in glioblastoma

  2024cites this paper
• Exploring the Role and Prognostic Value of TMEM208 in Head and Neck Squamous Cell Carcinoma

  2024cites this paper
• New Avenues and Major Achievements in Phytocompounds Research for Glioblastoma Therapy

  2024cites this paper
• In-silico study of asymmetric remodeling of tumors in response to external biochemical stimuli

  2023cites this paper
• CREB-induced LINC00473 promotes chemoresistance to TMZ in glioblastoma by regulating O6-methylguanine-DNA-methyltransferase expression via CEBPα binding.

  2023cites this paper
• Dihydroartemisinin suppresses glioma growth by repressing ERRα-mediated mitochondrial biogenesis

  2023cites this paper
• Unraveling the Anticancer Potential of Statins: Mechanisms and Clinical Significance

  2023cites this paper
• Transcriptomic analysis identifies the neuropeptide cortistatin (CORT) as an inhibitor of temozolomide (TMZ) resistance by suppressing the NF-κB-MGMT signaling axis in human glioma

  2023cites this paper
• The functions of exosomes targeting astrocytes and astrocyte-derived exosomes targeting other cell types

  2023cites this paper
• Unfolded Protein Response Signaling in Hepatic Stem Cell Activation in Liver Fibrosis.

  2023cites this paper
• HOXD‐AS2‐STAT3 feedback loop attenuates sensitivity to temozolomide in glioblastoma

  2023cites this paper
• EPIC-1042 as a potent PTRF/Cavin1-Caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for Glioblastoma.

  2023cites this paper
• Important Requirements for Desorption/Ionization Mass Spectrometric Measurements of Temozolomide-Induced 2′-Deoxyguanosine Methylations in DNA

  2023cites this paper
• Polyhedral Oligomeric Silsesquioxane-Based Nanoparticles for Efficient Chemotherapy of Glioblastoma.

  2023cites this paper
• Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients

  2023cites this paper
• A Comparison of Three Different Deep Learning-Based Models to Predict the MGMT Promoter Methylation Status in Glioblastoma Using Brain MRI

  2023cites this paper
• KIF18A interacts with PPP1CA to promote the malignant development of glioblastoma

  2023cites this paper
• E3 ligase MAEA-mediated ubiquitination and degradation of PHD3 promotes glioblastoma progression

  2023cites this paper
• Feasibility of Predicting O-6-methylguanine-DNA Methyltransferase Status in Glioblastoma Using MRI-based Radiomics Features

  2023cites this paper
• Regulation of Autophagy via Carbohydrate and Lipid Metabolism in Cancer

  2023cites this paper
• Abrogation of the G2/M checkpoint as a chemo sensitization approach for alkylating agents.

  2023cites this paper
• Mitochondrial Mechanisms in Temozolomide Resistance: Un-raveling the Complex Interplay and Therapeutic Strategies in Glioblastoma.

  2023cites this paper
• Biochanin A Sensitizes Glioblastoma to Temozolomide by Inhibiting Autophagy

  2022cites this paper
• A multi-omics analysis of glioma chemoresistance using a hybrid microphysiological model of glioblastoma

  2022cites this paper
• Overexpression of PRKCH promotes tumorigenesis in patients with glioma and influences glioma stem cell properties.

  2022cites this paper
• EID3 Promotes Glioma Cell Proliferation and Survival by Inactivating AMPKα1

  2022cites this paper
• TRIM47 promotes glioma angiogenesis by suppressing Smad4

  2022cites this paper
• Guggulsterone from Commiphora mukul potentiates anti-glioblastoma efficacy of temozolomide in vitro and in vivo via down-regulating EGFR/PI3K/Akt signaling and NF-κB activation.

  2022cites this paper
• STAT3-mediated upregulation of LINC00520 contributed to temozolomide chemoresistance in glioblastoma by interacting with RNA-binding protein LIN28B

  2022cites this paper
• Vibratome sectioning of tumors to evaluate the interactions between nanoparticles and the tumor microenvironment ex-vivo

  2022cites this paper
• Ameliorating effects of ramelteon on oxidative stress, inflammation, apoptosis, and autophagy markers in methotrexate-induced cerebral toxicity

  2022cites this paper
• Global research trends and hotspots on glioma stem cells

  2022cites this paper
• The E3 ubiquitin ligase HUWE1 acts through the N‐Myc‐DLL1‐NOTCH1 signaling axis to suppress glioblastoma progression

  2022cites this paper
• GBP3 promotes glioblastoma resistance to temozolomide by enhancing DNA damage repair

  2022cites this paper
• Tumor-Treating Fields in Glioblastomas: Past, Present, and Future

  2022cites this paper
• YTHDF2 promotes temozolomide resistance in glioblastoma by activation of the Akt and NF‐κB signalling pathways via inhibiting EPHB3 and TNFAIP3

  2022cites this paper
• lncRNA XLOC013218 promotes cell proliferation and TMZ resistance by targeting the PIK3R2‐mediated PI3K/AKT pathway in glioma

  2022cites this paper
• Temozolomide Resistance: A Multifarious Review on Mechanisms Beyond O‑6‑Methylguanine‑DNA Methyltransferase.

  2022cites this paper
• Glioblastoma Stem Cells—Useful Tools in the Battle against Cancer

  2022cites this paper
• The Phytochemical Potential for Brain Disease Therapy and the Possible Nanodelivery Solutions for Brain Access

  2022cites this paper
• Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?

  2022cites this paper
• The multifaceted mechanisms of malignant glioblastoma progression and clinical implications

  2022cites this paper
• Expression and Prognostic Role of Glia Maturation Factor-γ in Gliomas

  2022cites this paper
• Combining HDAC and MEK Inhibitors with Radiation against Glioblastoma-Derived Spheres

  2022cites this paper
• 7-Azaindole, 2,7-diazaindole, and 1H-pyrazole as core structures for novel anticancer agents with potential chemosensitizing properties.

  2022cites this paper
• Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy

  2022cites this paper
• Heme Oxygenase-1 targeting exosomes for temozolomide resistant glioblastoma synergistic therapy.

  2022cites this paper
• Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization

  2022cites this paper
• Reduced PTCH2 expression is associated with glioma development through its regulation of the PTEN/AKT signaling pathway.

  2022cites this paper
• Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma

  2022cites this paper
• CIMP-positive glioma is associated with better prognosis: A systematic analysis

  2022cites this paper
• Review on NAD(P)H dehydrogenase quinone 1 (NQO1) pathway

  2022cites this paper
• HIF-α activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis

  2022cites this paper
• Oncogenic Forkhead box D3 antisense RNA 1 promotes cell survival and confers temozolomide resistance in glioblastoma cells through the miR-128-3p/WEE1 G2 checkpoint kinase axis

  2022cites this paper
• Emerging immune-based technologies for high-grade gliomas

  2022cites this paper
• Approaching Sites of Action of Temozolomide for Pharmacological and Clinical Studies in Glioblastoma

  2021influential citation
• ELK3: A New Molecular Marker for the Diagnosis and Prognosis of Glioma

  2021cites this paper
• RSL3 Drives Ferroptosis through NF-κB Pathway Activation and GPX4 Depletion in Glioblastoma

  2021cites this paper
• LncRNA GAS5 Inhibits Temozolomide Chemoresistance to Glioma Via Inactivating Wnt/β-Catenin Pathway by Interacting with PTBP1

  2021cites this paper
• Against the Resilience of High-Grade Gliomas: The Immunotherapeutic Approach (Part I)

  2021cites this paper
• An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment

  2021cites this paper
• Endothelial Cells Immune-Related Genes Risk Signature Correlated With Tumor Immune Microenvironment Predicts Therapeutic Response and Prognosis in Glioblastoma

  2021cites this paper
• E2F transcription factor 1 elevates cyclin D1 expression by suppressing transcription of microRNA‐107 to augment progression of glioma

  2021cites this paper
• Therapeutic strategies of glioblastoma (GBM): The current advances in the molecular targets and bioactive small molecule compounds

  2021cites this paper
• Girdin Knockdown Increases Gemcitabine Chemosensitivity to Pancreatic Cancer by Modulating Autophagy

  2021cites this paper
• β-Elemene Triggers ROS-dependent Apoptosis in Glioblastoma Cells Through Suppressing STAT3 Signaling Pathway

  2021cites this paper
• Role of bioactive peptides derived from food proteins in programmed cell death to treat inflammatory diseases and cancer

  2021cites this paper